{"transactions":[{"id":737541,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T21:00:14.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":106393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":106393,"derivative":{"exercise_price":0.96,"expiration_date":"2036-06-11","underlying":"Class A Common Stock","underlying_shares":106393},"source":{"system":"sec-edgar","filing":"0001375927-26-000002","document":"form4-06152026_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000137592726000002/form4-06152026_050601.xml","form_type":"4"}},{"id":770122,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:05:31.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":251185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":251185,"derivative":{"exercise_price":0.8539,"expiration_date":"2036-05-18","underlying":"Class A Common Stock","underlying_shares":251185},"source":{"system":"sec-edgar","filing":"0001140361-26-022240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036126022240/form4.xml","form_type":"4"}},{"id":962912,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-18T14:00:09.000Z","date":"2025-12-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.52,"value":13000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.51 to $0.53. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001375927-25-000005","document":"form4-12182025_091205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000137592725000005/form4-12182025_091205.xml","form_type":"4"}},{"id":1127309,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T21:00:09.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":60339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":60339,"derivative":{"exercise_price":1.65,"expiration_date":"2035-05-29","underlying":"Class A Common Stock","underlying_shares":60339},"source":{"system":"sec-edgar","filing":"0001415889-25-015199","document":"form4-06022025_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000141588925015199/form4-06022025_050601.xml","form_type":"4"}},{"id":1139104,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-21T20:01:33.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":126095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":126095,"derivative":{"exercise_price":1.41,"expiration_date":"2035-05-19","underlying":"Class A Common Stock","underlying_shares":126095},"source":{"system":"sec-edgar","filing":"0001140361-25-020046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036125020046/form4.xml","form_type":"4"}},{"id":1149017,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"RSUs","published_at":"2025-05-15T00:31:54.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001753926-25-000828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625000828/form4.xml","form_type":"4"}},{"id":1149016,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Option","published_at":"2025-05-15T00:31:54.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001753926-25-000828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625000828/form4.xml","form_type":"4"}},{"id":1484587,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T21:00:17.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":31835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":31835,"derivative":{"exercise_price":3.4,"expiration_date":"2034-06-05","underlying":"Class A Common Stock","underlying_shares":31835},"source":{"system":"sec-edgar","filing":"0001415889-24-016246","document":"form4-06102024_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000141588924016246/form4-06102024_050601.xml","form_type":"4"}},{"id":1511638,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T20:46:22.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":113281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Makes' continued service through the applicable vesting date."}],"balance_after":113281,"derivative":{"exercise_price":1.86,"expiration_date":"2034-05-16","underlying":"Class A Common Stock","underlying_shares":113281},"source":{"system":"sec-edgar","filing":"0001140361-24-026706","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124026706/form4.xml","form_type":"4"}},{"id":1517258,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-14T22:48:31.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001753926-24-000964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392624000964/ownership.xml","form_type":"4"}},{"id":1517257,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Option","published_at":"2024-05-14T22:48:31.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.81,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001753926-24-000964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392624000964/ownership.xml","form_type":"4"}},{"id":1706934,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-19T01:27:58.000Z","date":"2023-12-18","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.87,"value":870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001753926-23-001593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623001593/ownership.xml","form_type":"4"}},{"id":1706933,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-19T01:27:58.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.89,"value":3560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001753926-23-001593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623001593/ownership.xml","form_type":"4"}},{"id":1788926,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-09-05T23:04:50.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.945,"value":3780.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001753926-23-001190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623001190/ownership.xml","form_type":"4"}},{"id":1788925,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-09-05T23:04:50.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.9,"value":1800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001753926-23-001190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623001190/ownership.xml","form_type":"4"}},{"id":1841922,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-06-29T16:43:34.000Z","date":"2023-06-28","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":1.21,"value":3630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001753926-23-000869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623000869/ownership.xml","form_type":"4"}},{"id":1841921,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-06-29T16:43:34.000Z","date":"2023-06-27","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.24,"value":1240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001753926-23-000869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623000869/ownership.xml","form_type":"4"}},{"id":1858458,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T15:31:55.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2033-06-07","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009586","document":"form4-06122023_030652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000141588923009586/form4-06122023_030652.xml","form_type":"4"}},{"id":1891691,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-16T21:01:41.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":120481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Makes' continued service through the applicable vesting date."}],"balance_after":120481,"derivative":{"exercise_price":1.41,"expiration_date":"2033-05-12","underlying":"Class A Common Stock","underlying_shares":120481},"source":{"system":"sec-edgar","filing":"0001140361-23-025063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123025063/form4.xml","form_type":"4"}},{"id":1962991,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"RSUs","published_at":"2023-03-09T02:33:16.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire."}],"balance_after":75000,"derivative":{"exercise_date":"2023-03-06","expiration_date":"2027-03-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001753926-23-000261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623000261/ownership.xml","form_type":"4"}},{"id":1962990,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"RSUs","published_at":"2023-03-09T02:33:16.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire."}],"balance_after":37500,"derivative":{"exercise_date":"2023-03-06","expiration_date":"2027-03-06","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001753926-23-000261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623000261/ownership.xml","form_type":"4"}},{"id":2048574,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-24T02:11:40.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one year and monthly for 36 months thereafter on a equal basis."}],"balance_after":75000,"derivative":{"exercise_price":1.27,"exercise_date":"2024-01-19","expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001753926-23-000080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623000080/ownership.xml","form_type":"4"}},{"id":2048573,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-24T02:11:40.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one year and monthly for 36 months thereafter on a equal basis."}],"balance_after":75000,"derivative":{"exercise_price":1.27,"exercise_date":"2024-01-14","expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001753926-23-000080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392623000080/ownership.xml","form_type":"4"}},{"id":2089404,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-12T22:08:32.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":2000,"price":3.65,"value":7300.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-012417","document":"form4-12122022_101207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000141588922012417/form4-12122022_101207.xml","form_type":"4"}},{"id":2120993,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-10T01:11:04.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest monthly equally over a four-year period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Awarded as compensation for serving as CFO."}],"balance_after":50000,"derivative":{"exercise_price":1.77,"exercise_date":"2022-12-07","expiration_date":"2032-11-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001753926-22-001443","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001443/ownership.xml","form_type":"4"}},{"id":2157198,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-09-16T22:55:59.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":13584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest immediately."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Awarded as compensation for serving as CFO."}],"balance_after":13584,"derivative":{"exercise_price":2.8,"exercise_date":"2022-09-14","expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":13584},"source":{"system":"sec-edgar","filing":"0001753926-22-001276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392622001276/ownership.xml","form_type":"4"}},{"id":2237369,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T12:34:48.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":22090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":22090,"derivative":{"exercise_price":6.28,"expiration_date":"2032-06-06","underlying":"Class A Common Stock","underlying_shares":22090},"source":{"system":"sec-edgar","filing":"0001415889-22-006334","document":"form4-06092022_050640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000141588922006334/form4-06092022_050640.xml","form_type":"4"}},{"id":2242564,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director's Deferred Share Units","published_at":"2022-06-06T20:14:09.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":361680,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."}],"balance_after":643804,"derivative":{"underlying":"Subordinate Voting Shares"},"source":{"system":"sec-edgar","filing":"0001209191-22-034503","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122034503/doc4a.xml","form_type":"4/A","original_submission_date":"2022-06-03"}},{"id":2242563,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T20:14:09.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":100308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $0.75 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares underlying the option vest and become exercisable on June 1, 2023; the remaining 2/3rds of the shares underlying the option shall vest in equal installments, vesting at the end of each month thereafter for the succeeding 24 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":194358,"derivative":{"exercise_price":0.6,"expiration_date":"2027-05-31","underlying":"Subordinate Voting Shares","underlying_shares":100308},"source":{"system":"sec-edgar","filing":"0001209191-22-034503","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122034503/doc4a.xml","form_type":"4/A","original_submission_date":"2022-06-03"}},{"id":2242562,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subordinate Voting Shares","published_at":"2022-06-06T20:14:09.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":64656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in equal installments over 36 months beginning on June 1, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":158706,"source":{"system":"sec-edgar","filing":"0001209191-22-034503","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122034503/doc4a.xml","form_type":"4/A","original_submission_date":"2022-06-03"}},{"id":2245055,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director's Deferred Share Units","published_at":"2022-06-04T01:22:59.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":361680,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents Directors' Deferred Share Units (\"DDSUs\") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the \"Plan\"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators\n(defined in the Plan)."}],"balance_after":643804,"derivative":{"underlying":"Subordinate Voting Shares"},"source":{"system":"sec-edgar","filing":"0001209191-22-034418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122034418/doc4.xml","form_type":"4"}},{"id":2245054,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-04T01:22:59.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":100308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $0.75 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares underlying the option vest and become exercisable on June 1, 2023; the remaining 2/3rds of the shares underlying the option shall vest in equal installments, vesting at the end of each month thereafter for the succeeding 24 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":194358,"derivative":{"exercise_price":0.6,"expiration_date":"2017-05-31","underlying":"Subordinate Voting Shares","underlying_shares":100308},"source":{"system":"sec-edgar","filing":"0001209191-22-034418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122034418/doc4.xml","form_type":"4"}},{"id":2245053,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subordinate Voting Shares","published_at":"2022-06-04T01:22:59.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":64656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in equal installments over 36 months beginning on June 1, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":158706,"source":{"system":"sec-edgar","filing":"0001209191-22-034418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122034418/doc4.xml","form_type":"4"}},{"id":2258479,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subordinate Voting Shares","published_at":"2022-05-24T20:51:08.000Z","date":"2022-05-11","kind":"other","acquired":true,"shares":67678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Savant Addition Medicine, LLC, of which the Reporting Person is a non-managing member."}],"balance_after":94050,"source":{"system":"sec-edgar","filing":"0001209191-22-031636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122031636/doc4.xml","form_type":"4"}},{"id":2272207,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-05-13T20:17:50.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":59880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Makes' continued service through the applicable vesting date."}],"balance_after":59880,"derivative":{"exercise_price":3.06,"expiration_date":"2032-05-11","underlying":"Class A Common Stock","underlying_shares":59880},"source":{"system":"sec-edgar","filing":"0001140361-22-019084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036122019084/form4.xml","form_type":"4"}},{"id":2670414,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-14T22:56:44.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":20512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on June 11, 2022, subject to Ms. Makes's continued service through the applicable vesting date"}],"balance_after":20512,"source":{"system":"sec-edgar","filing":"0001104659-21-080934","document":"tm2119549-24_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000110465921080934/tm2119549-24_4seq1.xml","form_type":"4"}},{"id":2675210,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T21:46:36.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":14082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":14082,"derivative":{"exercise_price":10.41,"expiration_date":"2031-06-06","underlying":"Class A Common Stock","underlying_shares":14082},"source":{"system":"sec-edgar","filing":"0001415889-21-002899","document":"form4-06092021_020621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000141588921002899/form4-06092021_020621.xml","form_type":"4"}},{"id":2949852,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":38078,"kind":"person","name":"Makes Brigid","position":1,"cik":"0001375927","reported_name":"Makes Brigid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2020-12-10T21:42:15.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":14307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in three equal installments on each of October 8, 2021, 2022 and 2023."}],"balance_after":14307,"derivative":{"exercise_price":17,"expiration_date":"2030-12-08","underlying":"CLASS A COMMON STOCK","underlying_shares":14307},"source":{"system":"sec-edgar","filing":"0001104659-20-134237","document":"tm2038235-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375927/000110465920134237/tm2038235-1_4seq1.xml","form_type":"4"}}]}